Last reviewed · How we verify

NCT05193149: IMOCS

Inspiratory Muscle Training in Obese Breast Cancer Survivors

Recruiting now NA Last updated 7 January 2026
What this trial tests

NA trial testing Inspiratory muscle training in Cancer Survivors in 78 participants. Currently enrolling.

Timeline
13 November 2023
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorOhio State University Comprehensive Cancer Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment78
Start date13 November 2023
Primary completion30 June 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ohio State University Comprehensive Cancer Center

Who can join

18 and older, female only, with Cancer Survivors or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Potential Therapeutic Role of Respiratory Muscle Training in Dyspnea Management of Cancer Survivors: A Narrative Review.
    Vainshelboim B, Sardesai SD, Bhammar D. · · 2024 · cited 1× · PMID 38751708 · DOI 10.14740/wjon1781

Verify or expand the search:

Other trials of Inspiratory muscle training

Trials testing the same drug.

Other recruiting trials for Cancer Survivors

Currently open trials in the same condition.

Other Ohio State University Comprehensive Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05193149.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing